Total Payments
$2,245
2024 Payments
$812.69
Companies
14
Transactions
118
Medicare Patients
419
Medicare Billing
$38,999
Payment Breakdown by Category
Food & Beverage$2,245 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,245 | 118 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $547.91 | 33 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $441.58 | 30 | $0 (2024) |
| ABBVIE INC. | $380.01 | 18 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $205.34 | 6 | $0 (2024) |
| ITI, Inc. | $181.24 | 5 | $0 (2023) |
| Alkermes, Inc. | $162.68 | 9 | $0 (2024) |
| Indivior Inc. | $130.41 | 6 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $49.04 | 3 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $35.86 | 2 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $30.83 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $812.69 | 48 | Teva Pharmaceuticals USA, Inc. ($228.75) |
| 2023 | $706.83 | 41 | Otsuka America Pharmaceutical, Inc. ($152.36) |
| 2022 | $552.05 | 23 | Otsuka America Pharmaceutical, Inc. ($241.26) |
| 2021 | $173.79 | 6 | AbbVie Inc. ($132.19) |
All Payment Transactions
118 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $17.23 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/17/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Central Nervous System | ||||||
| 12/03/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $9.68 | General |
| Category: Central Nervous System | ||||||
| 11/15/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Central Nervous System | ||||||
| 10/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.75 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: CNS | ||||||
| 10/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/09/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: OUD | ||||||
| 10/01/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $8.64 | General |
| Category: PSYCHIATRY | ||||||
| 10/01/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $2.02 | General |
| Category: PSYCHIATRY | ||||||
| 09/24/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: PSYCHIATRY | ||||||
| 09/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: PSYCHIATRY | ||||||
| 09/11/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: CNS | ||||||
| 09/05/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $27.27 | General |
| Category: CNS | ||||||
| 07/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: PSYCHIATRY | ||||||
| 07/09/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $8.29 | General |
| Category: Neurology | ||||||
| 06/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: NEUROSCIENCE | ||||||
| 06/11/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: PSYCHIATRY | ||||||
| 05/28/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: PSYCHIATRY | ||||||
| 05/17/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Neurology | ||||||
| 05/17/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $4.98 | General |
| Category: Central Nervous System | ||||||
| 05/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: PSYCHIATRY | ||||||
| 05/06/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 106 | 243 | $34,720 | $9,985 |
| 2022 | 3 | 127 | 270 | $32,305 | $12,987 |
| 2021 | 2 | 139 | 302 | $25,115 | $13,068 |
| 2020 | 2 | 47 | 126 | $10,080 | $2,959 |
Total Patients
419
Total Services
941
Medicare Billing
$38,999
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 92 | 229 | $32,060 | $9,015 | 28.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 14 | $2,660 | $970.01 | 36.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 94 | 237 | $26,745 | $10,595 | 39.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 16 | 16 | $3,360 | $1,500 | 44.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 17 | 17 | $2,200 | $891.90 | 40.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 120 | 282 | $23,235 | $12,021 | 51.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 19 | 20 | $1,880 | $1,048 | 55.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 34 | 113 | $9,040 | $2,652 | 29.3% |
| G0459 | Inpatient telehealth pharmacologic management, including prescription, use, and review of medication with no more than minimal medical psychotherapy | Office | 2020 | 13 | 13 | $1,040 | $306.61 | 29.5% |
About Jill Brabant, ARNP
Jill Brabant, ARNP is a Mental Health healthcare provider based in Gouverneur, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1326120692.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jill Brabant, ARNP has received a total of $2,245 in payments from pharmaceutical and medical device companies, with $812.69 received in 2024. These payments were reported across 118 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($2,245).
As a Medicare-enrolled provider, Brabant has provided services to 419 Medicare beneficiaries, totaling 941 services with total Medicare billing of $38,999. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Mental Health
- Other Specialties Mental Health, Psychiatric/Mental Health
- Location Gouverneur, NY
- Active Since 10/19/2006
- Last Updated 02/18/2015
- Taxonomy Code 101YM0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1326120692
Products in Payments
- VRAYLAR (Drug) $380.01
- ABILIFY MAINTENA (Drug) $275.24
- REXULTI (Drug) $244.77
- CAPLYTA (Drug) $230.28
- INGREZZA (Drug) $205.34
- Austedo XR (Drug) $185.07
- UZEDY (Drug) $153.73
- ARISTADA (Drug) $114.68
- PERSERIS (Drug) $106.23
- AUSTEDO (Drug) $102.78
- INVEGA SUSTENNA (Drug) $35.86
- ABILIFY ASIMTUFII (Drug) $29.63
- Vivitrol (Drug) $27.62
- HYRIMOZ (Biological) $26.61
- SUBLOCADE (Drug) $24.18
- SIGNIA (Device) $23.01
- LYBALVI (Drug) $20.38
- FANAPT (Drug) $17.57
- COBENFY (Drug) $17.23
- HETLIOZ (Drug) $13.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.